Gene Amplification Technologies Market: Current Analysis and Forecast (2022-2028)

The gene amplification technologies market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Gene amplification technology is a critical component of genomics that is widely used in diagnostics. For various studies, it assists in increasing the number of copies of a gene. Gene amplification is frequently carried out using dendritic polymers, transcription-mediated amplification, polymerase chain reaction to ligase chain reaction, and other methods. The main purpose of gene amplification technology is to compare the gene of the study sample with the genes of other germline or somatic cells. The growing demand for gene amplification technologies can be attributed to the expanding need for research and development in the fields of genetic testing, molecular diagnostics, and genomics which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in august 2022, QIAGEN launched new solutions that significantly accelerate DNA variant detection and RNA sequencing of low-input samples. QIAseq Targeted DNA Pro Panels are based on improved chemistry that halves to six hours the time researchers need for library preparation of DNA samples. Owing to the glaring statistics the increasing development of numerous diagnostic tests based on various gene amplification methods led to the growing demand for gene amplification technologies and would contribute to the growth of the market in the forthcoming period as well. In addition, the introduction of novel and advanced products and the growing acceptance of personalized medicine are likely to aid the market growth. Furthermore, the gene amplification technologies market is anticipated to grow on account of government regulations, decreasing sequencing costs together boosting the research field. However, some of the restraints in the market including the high costs of these technologies and limited awareness about genome sequencing are impeding the growth of this market all over the world.

Based on the technology, the gene amplification technologies market is segmented into PCR-based amplification, multiple displacement amplification, isothermal DNA amplification, and others. The PCR-based amplification segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR for COVID-19 detection has resulted in significant revenue generation by this technology.

Based on the application, the market is fragmented into whole genome amplification, exome sequencing, SNP genotyping arrays, array CGH, hybridization, and others. The hybridization segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. In the hybridization process, several multiplication technologies are increasingly being used.

Based on the end-users, the market is fragmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic & research institutes, and others. The pharmaceutical & biotechnology companies segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. These businesses are concentrating on the creation of molecular diagnostic tests based on amplification techniques, which is promoting market expansion. Additionally, the market is expected to grow due to the expansion of applications in areas such as drug discovery, food quality control, bioremediation, and others.

For a better understanding of the market adoption of gene amplification technologies, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the gene amplification technologies industry owing to the presence of various genetic research programs in the region, as well as strong research and a commercial base for gene multiplication products, and growing funding by numerous government organizations in medical research and its infrastructure, which are the major factors contributing to the growth of the market.

Some of the major players operating in Qiagen NV; New England Biolabs; Illumina, Inc.; Bio-Rad Laboratories, Inc.; BGI Genomics Co Ltd; Oxford Nanopore Technologies PLC; PerkinElmer, Inc.; Becton Dickinson and Co; Bayer AG; AND Agilent Technologies Inc among others. Several M&A's along with partnerships have been undertaken by these players.